New Zealand markets open in 7 hours 49 minutes

Sanofi (SNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
53.20+2.00 (+3.91%)
As of 10:11AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 127.23B
Enterprise value 137.47B
Trailing P/E 26.14
Forward P/E 12.33
PEG ratio (5-yr expected) 0.93
Price/sales (ttm)2.53
Price/book (mrq)1.60
Enterprise value/revenue 2.71
Enterprise value/EBITDA 14.03

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3-4.37%
S&P500 52-week change 319.61%
52-week high 355.72
52-week low 342.63
50-day moving average 349.13
200-day moving average 348.69

Share statistics

Avg vol (3-month) 32.36M
Avg vol (10-day) 32M
Shares outstanding 52.5B
Implied shares outstanding 62.53B
Float 81.1B
% held by insiders 10.00%
% held by institutions 110.35%
Shares short (15 Jul 2024) 49.55M
Short ratio (15 Jul 2024) 43.31
Short % of float (15 Jul 2024) 40.43%
Short % of shares outstanding (15 Jul 2024) 40.38%
Shares short (prior month 14 Jun 2024) 47.82M

Dividends & splits

Forward annual dividend rate 42.04
Forward annual dividend yield 43.98%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 43.71
Payout ratio 498.11%
Dividend date 306 Jun 2024
Ex-dividend date 409 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in EUR.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 9.80%
Operating margin (ttm)18.28%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)46.29B
Revenue per share (ttm)18.49
Quarterly revenue growth (yoy)2.30%
Gross profit (ttm)N/A
EBITDA 12.2B
Net income avi to common (ttm)4.54B
Diluted EPS (ttm)1.96
Quarterly earnings growth (yoy)-43.20%

Balance sheet

Total cash (mrq)8.71B
Total cash per share (mrq)6.98
Total debt (mrq)18.42B
Total debt/equity (mrq)24.78%
Current ratio (mrq)N/A
Book value per share (mrq)59.17

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A